Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Brain Ischemia

• Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
• Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
• RESTORE: buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
• Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
• Satralizumab in Aneurysmal Subarachnoid Hemorrhage
• Neonatal Brain Ultrasound With CEUS and Elastography
• MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial
• A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
• A Phase I Safety and Feasibility of Metformin Treatment in Infants After Perinatal Brain Injury
• A Multicenter, Randomized Trial to Assess Safety, and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
• PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
• Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke
• Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.
• For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
• Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm
• Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)
• Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
• Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)
• Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
• NVD in Hypothermic HIE Neonates
• Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
• Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia
• Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
• PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
• Caffeine for Hypoxic-Ischemic Encephalopathy
• RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
• CEUS Evaluation of Hypoxic Ischemic Injury
• Fluoxetine Opens Window to Improve Motor Recovery After Stroke
• Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial
• Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy
• Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
• PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns
• Mild Encephalopathy in the Newborn Treated With Darbepoetin
• Effect of Sedatives on Regional Cerebral Oxygen Saturation
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
• Early Administration of Aspirin in Patients With Acute Ischemic Stroke Treated With Systemic Thrombolysis
• Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
• Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns
• General Anesthesia for Endovascular Thrombectomy; A Pilot Study.
• Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia
• Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
• Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia
• PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
• Helping Stroke Patients With ThermoSuit Cooling
• Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke
• Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy
• Field Randomization of NA-1 Therapy in Early Responders
• Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
• Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage
• Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
• Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke
• Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth
• NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic Encephalopathy
• Evaluation of the Biological Response to Clopidogrel in Patients With Ischemic Stroke
• Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
• Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy
• Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
• Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions
• Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage
• Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy
• Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
• Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy
• Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
• Xarelto [SPAF] Post-marketing Surveillance in Japan
• Use of Minocicline in Patients With Stroke
• Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth
• Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
• Desflurane Versus Propofol in the Sitting Position
• Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation
• Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With Hypothermia
• Efficiency Study of Siwu Tang to Treat Brain Hypoperfusion Syndrome
• Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy
• PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
• Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
• Effect of Xenon and Therapeutic Hypothermia, on the Brain and on Neurological Outcome Following Brain Ischemia in Cardiac Arrest Patients
• Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility Study
• Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia
• Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
• Neonatal Erythropoietin in Asphyxiated Term Newborns
• Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy
• Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke
• Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
• Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke
• ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
• Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke
• Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
• Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth
• A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)